Sunesis Pharmaceuticals, Inc. (SNSS)
Q3 2019 Earnings Conference Call
November 12, 2019 04:30 AM ET
Executives
Willie Quinn - Chief Financial Officer & Senior Vice President, Corporate Development
Dayton Misfeldt - Interim Chief Executive Officer
Judy Fox - Chief Scientific Officer
Par Hyare - Senior Vice President Commercial
Deepali Suri - Vice President, Clinical Operations
Analysts
Justin Kim - Oppenheimer
Kenneth Atkins - Cowen
Presentation
Operator
Good afternoon, ladies and gentlemen, and welcome to the Q3 2019 Sunesis Pharmaceuticals Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we